Collapsing goods in medicine and the value of innovation

Journal of Value Inquiry

Volumn 40, Issue 2-3, 2006, Pages 155-168

  Magnell, Thomas ^a  

^a DREW UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34548682964     PISSN: 00225363     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10790-007-9032-5     Document Type: Article

References (12)

1. Stuart B. Levy, "The Challenge of Antibiotic Resistance," Scientific American 278, No. 3 (Mar. 1998), p. 46.
2. Ibid., pp. 50-51.
3. Laurie Garrett, The Coming Plague (New York: Penguin Books, 1995), p. 589.
4. Ibid., p. 590.
5. See Michael B. A. Oldstone, Viruses, Plagues, and History (New York: Oxford University Press, 1998), pp. 32-33.
6. See David Suzuki and Peter Knudson, Genethics (Cambridge, Mass.: Harvard University Press, 1990), pp. 296-298.
7. See Garrett Hardin, "The Tragedy of the Commons," Science 162 (13 Dec. 1968);
8. also in Hardin, Exploring New Ethics for Survival: The Voyage of the Spaceship Beagle (New York: Penguin Books, 1972).
9. See Alan Gewirth, Reason and Morality (Chicago: Chicago University Press, 1981).
10. See Marcus George Singer, Generalization in Ethics (New York: Alfred A. Knopf, 1961).
11. See Thomas Magnell, "Present Concerns and Future Interests," in Joram Graf Haber, ed., Ethics in the 90s, (Belmont, Calif.: Wadsworth Publishing, 1997).
12. Many of the ideas in this paper were stimulated by discussions I enjoyed as a Fellow in Medical Ethics and also as a Lecturer in Medical Ethics in the Division of Medical Ethics in the Department of Social Medicine at Harvard Medical School. In particular, I would like to thank Robert Truog and Walter Robinson for their pointed questioning and thoughtful probing of received opinion on moral matters in medicine.